Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay.

Lee SJ, Levitsky K, Parlati F, Bennett MK, Arastu-Kapur S, Kellerman L, Woo TF, Wong AF, Papadopoulos KP, Niesvizky R, Badros AZ, Vij R, Jagannath S, Siegel D, Wang M, Ahmann GJ, Kirk CJ.

Br J Haematol. 2016 Jun;173(6):884-95. doi: 10.1111/bjh.14014. Epub 2016 Apr 12.

2.

An in silico method to identify computer-based protocols worthy of clinical study: An insulin infusion protocol use case.

Wong AF, Pielmeier U, Haug PJ, Andreassen S, Morris AH.

J Am Med Inform Assoc. 2016 Mar;23(2):283-8. doi: 10.1093/jamia/ocv067. Epub 2015 Jul 30.

3.

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study.

Jakubowiak AJ, Siegel DS, Martin T, Wang M, Vij R, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi F, Reu FJ, Somlo G, Zonder J, Song K, Stewart AK, Stadtmauer E, Harrison BL, Wong AF, Orlowski RZ, Jagannath S.

Leukemia. 2013 Dec;27(12):2351-6. doi: 10.1038/leu.2013.152. Epub 2013 May 14.

4.

Phase Ib dose-escalation study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma.

Niesvizky R, Martin TG 3rd, Bensinger WI, Alsina M, Siegel DS, Kunkel LA, Wong AF, Lee S, Orlowski RZ, Wang M.

Clin Cancer Res. 2013 Apr 15;19(8):2248-56. doi: 10.1158/1078-0432.CCR-12-3352. Epub 2013 Feb 27.

5.

Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety.

Badros AZ, Vij R, Martin T, Zonder JA, Kunkel L, Wang Z, Lee S, Wong AF, Niesvizky R.

Leukemia. 2013 Aug;27(8):1707-14. doi: 10.1038/leu.2013.29. Epub 2013 Jan 31.

6.

An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib.

Vij R, Siegel DS, Jagannath S, Jakubowiak AJ, Stewart AK, McDonagh K, Bahlis N, Belch A, Kunkel LA, Wear S, Wong AF, Wang M.

Br J Haematol. 2012 Sep;158(6):739-48. doi: 10.1111/j.1365-2141.2012.09232.x. Epub 2012 Jul 30.

7.

A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma.

Siegel DS, Martin T, Wang M, Vij R, Jakubowiak AJ, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi F, Reu FJ, Somlo G, Zonder J, Song K, Stewart AK, Stadtmauer E, Kunkel L, Wear S, Wong AF, Orlowski RZ, Jagannath S.

Blood. 2012 Oct 4;120(14):2817-25. doi: 10.1182/blood-2012-05-425934. Epub 2012 Jul 25.

8.

A confirmatory factor analytic approach on perceptions of knowledge and skills in teaching (PKST).

Choy D, Lim KM, Chong S, Wong AF.

Psychol Rep. 2012 Apr;110(2):589-97.

PMID:
22662412
9.

An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma.

Vij R, Wang M, Kaufman JL, Lonial S, Jakubowiak AJ, Stewart AK, Kukreti V, Jagannath S, McDonagh KT, Alsina M, Bahlis NJ, Reu FJ, Gabrail NY, Belch A, Matous JV, Lee P, Rosen P, Sebag M, Vesole DH, Kunkel LA, Wear SM, Wong AF, Orlowski RZ, Siegel DS.

Blood. 2012 Jun 14;119(24):5661-70. doi: 10.1182/blood-2012-03-414359. Epub 2012 May 3.

10.

The Physiological Cost Index of walking with an isocentric reciprocating gait orthosis among patients with T(12) - L(1) spinal cord injury.

Leung AK, Wong AF, Wong EC, Hutchins SW.

Prosthet Orthot Int. 2009 Mar;33(1):61-8. doi: 10.1080/03093640802562368.

PMID:
19235067
11.

The bereaved parent.

Russo C, Wong AF.

J Clin Oncol. 2005 Nov 1;23(31):8109-11. Review. No abstract available.

PMID:
16258108
12.

Review of clinical manifestations of biochemically-advanced prostate cancer cases.

Chiong E, Wong AF, Chan YH, Chin CM.

Asian J Surg. 2005 Jul;28(3):202-6.

13.

Use of ATP-MgCl2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects.

Brook MM, Fineman JR, Bolinger AM, Wong AF, Heymann MA, Soifer SJ.

Circulation. 1994 Sep;90(3):1287-93.

PMID:
8087937
14.

Antifungal agents and their renal implications in the neonate.

Levin RH, Wong AF.

J Perinat Neonatal Nurs. 1994 Jun;8(1):59-73. Review.

PMID:
8006806
15.

Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates.

Wong AF, McCulloch LM, Sola A.

J Pediatr. 1992 Dec;121(6):980-3.

PMID:
1447671
16.

Complications of home parenteral nutrition.

Herfindal ET, Bernstein LR, Wong AF, Hogue VW, Darbinian JA.

Clin Pharm. 1992 Jun;11(6):543-8.

PMID:
1600687
17.

Evaluation of cost-effectiveness research: a survey of recent publications.

Ganiats TG, Wong AF.

Fam Med. 1991 Aug;23(6):457-62.

PMID:
1936722
18.

Influenza in nursing homes.

Ganiats TG, Wong AF.

Ann Intern Med. 1988 Apr;108(4):644-5. No abstract available.

PMID:
3126692
19.

A rapid and simple blood sugar determination using the Ames reflectance meter and Dextrostix system: a preliminary report.

Cheah JS, Wong AF.

Singapore Med J. 1974 Mar;15(1):51-2. No abstract available.

PMID:
4841543
20.

The prevalence and causes of glycosuria in 28,765 young men in the population in Singapore.

Cheah JS, Tan BY, Wong AF.

Singapore Med J. 1971 Dec;12(6):314-8. No abstract available.

PMID:
5141588

Supplemental Content

Support Center